ReShape Lifesciences's total assets for Q2 2024 were $6.39M, a decrease of -22.33% from the previous quarter. RSLS total liabilities were $3.36M for the fiscal quarter, a -9.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.